Anna Bucsics
Impact in
- Economics and Econometrics top 0.5%
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
-
- Antibiotic Use and Resistance
Papers in
-
- Pharmaceutical Economics and Policy 26
- Health Systems, Economic Evaluations, Quality of Life 6
- Co-authors
- Brian Godman (8 shared papers)Thomas H. Burkhardt (7 shared papers)Jutta Piessnegger (3 shared papers)Björn Wettermark (2 shared papers)Wolfgang C. Winkelmayer (6 shared papers)Nina Zimmermann (1 shared paper)Claudia Habl (1 shared paper)Sabine Vogler (1 shared paper)
- Journals
- Frontiers in Pharmacology (10 papers)Health Policy (2 papers)International Journal of Technology Assessment in Health Care (2 papers)BMC Medicine (2 papers)Orphanet Journal of Rare Diseases (2 papers)
- Partner nations
- United KingdomSwedenAustria
In The Last Decade
Anna Bucsics
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 65
- Economics and Econometrics 819
- Applied Microbiology and Biotechnology 32
- Geriatrics and Gerontology 16
- Family Practice 8
- Toxicology 13
Countries citing papers authored by Anna Bucsics
This map shows the geographic impact of Anna Bucsics's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bucsics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bucsics more than expected).
Fields of papers citing papers by Anna Bucsics
This network shows the impact of papers produced by Anna Bucsics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bucsics. The network helps show where Anna Bucsics may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Bucsics, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 121 | |
| 2 | 2014 | 113 | |
| 3 | 2014 | 110 | |
| 4 | 2018 | 89 | |
| 5 | 2013 | 78 | |
| 6 | 2013 | 74 | |
| 7 | 2008 | 63 | |
| 8 | Discounts and rebates granted to public payers for medicines in European countries. | 2012 | 60 |
| 9 | 2017 | 55 | |
| 10 | 2014 | 53 | |
| 11 | 2009 | 52 | |
| 12 | 2016 | 48 | |
| 13 | 2018 | 44 | |
| 14 | 2014 | 42 | |
| 15 | 2016 | 41 | |
| 16 | 2017 | 40 | |
| 17 | 2019 | 38 | |
| 18 | 2014 | 37 | |
| 19 | 2019 | 33 | |
| 20 | 2020 | 27 |
About Anna Bucsics
Anna Bucsics is a scholar working on Economics and Econometrics, Geriatrics and Gerontology, Health Information Management, Hepatology and Statistics and Probability, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (26 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Electronic Health Records Systems (1 paper), Hepatitis C virus research (1 paper), Acute Myocardial Infarction Research (1 paper), Diabetes Treatment and Management (1 paper), Statistical Methods in Clinical Trials (1 paper) and Lipoproteins and Cardiovascular Health (1 paper). The work is most often cited by research in Economics and Econometrics (819 citations), Applied Microbiology and Biotechnology (32 citations), Geriatrics and Gerontology (16 citations), Family Practice (8 citations) and Toxicology (13 citations). Anna Bucsics has collaborated with scholars based in United Kingdom, Sweden and Austria. Frequent co-authors include Brian Godman, Thomas H. Burkhardt, Jutta Piessnegger, Björn Wettermark, Wolfgang C. Winkelmayer, Nina Zimmermann, Claudia Habl, Sabine Vogler, Berthold Reichardt and Alan R Haycox. Their work appears in journals such as Frontiers in Pharmacology, Health Policy, International Journal of Technology Assessment in Health Care, BMC Medicine and Orphanet Journal of Rare Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.